Ascentage Pharma Group International (AAPG) Non-Current Deferred Tax Liability (2022 - 2024)
Ascentage Pharma Group International (AAPG) has 1 years of Non-Current Deferred Tax Liability data on record, last reported at $2.2 million in Q4 2023.
- For Q4 2023, Non-Current Deferred Tax Liability changed N/A year-over-year to $2.2 million; the TTM value through Dec 2023 reached $2.2 million, changed N/A, while the annual FY2023 figure was $2.3 million, N/A changed from the prior year.
- Non-Current Deferred Tax Liability reached $2.2 million in Q4 2023 per AAPG's latest filing.
- Across five years, Non-Current Deferred Tax Liability topped out at $2.2 million in Q4 2023 and bottomed at $2.2 million in Q4 2023.